Pathogenic bacteria in the gastrointestinal tract (GI pathogens)

Pathogenic bacteria in the gastrointestinal tract encompass a diverse group of microorganisms, including species like Escherichia coli, Salmonella, and Clostridioides difficile, that cause disease upon colonization or toxin production (NIH, 2023). These organisms disrupt the normal physiological function of the gut, leading to symptoms ranging from mild diarrhea to life-threatening systemic infections (StatPearls, 2023). In the context of pharmacology, these bacteria are the subjects of antimicrobial therapy rather than being single molecular targets themselves (PubMed, 2022). Antibiotics and other therapeutic agents interact with specific bacterial components—such as the cell wall, ribosomes, or DNA gyrase—to inhibit growth or induce cell death (NIH, 2023). Managing these pathogens is a critical aspect of treating infectious diseases, though it poses challenges such as the development of multi-drug resistance and the collateral damage to beneficial gut flora (CDC, 2022).

Other names

Enteric pathogensGastrointestinal pathogensGut pathogensPathogenic gut microbiota

Antimicrobial agents target specific bacterial processes such as cell wall synthesis, protein synthesis, or DNA replication to eliminate the pathogen (NIH, 2023).